In another relatively unsurprising finding, a paper in JAMA Internal Medicine has suggested that– from a clinical point of view — there is little difference in the outcomes of men treated with older rather than newer forms of radiation therapy after first-line surgery for localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: 3D-CRT, adjuvant, IMRT, ouctome, prostatectomy, radiation, salvage, second-line | 2 Comments »
New data from the ARTS study, reported in European Urology, suggests that dutateride may have a role in the treatment of men with biochemical failure after radical first-line therapy for prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: ARTS, biochemical progression, dutasteride, outcome, second-line | 2 Comments »
The use of second-line radiation therapy following biochemical progression after first-line radiation therapy for localized forms of prostate cancer has long been limited by concerns about tolerance for rectal and related radiation toxicities. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: radiation therapy, re-irradiation, second-line | 3 Comments »
A recent study published in “The Red Journal” suggests (perhaps not surprisingly) that radiation oncologists and urologists have different mindsets about the application of immediate adjuvant radiation therapy following surgery for prostate cancer patients with a variety of adverse pathologic risk factors. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, radiation, salvage, second-line | 7 Comments »
Historically there have been few really compelling data available to support the use of an additional or alternative antiandrogen as a second-line agent to extend either progression-free or overall survival of castration-resistant prostate cancer (CRPC) patients who progress after first-line hormone therapy (whether they have been treated by orchiectomy or medical castration with an LHRH agonist). … READ MORE …
Filed under: Management, Treatment | Tagged: antiandrogen, bicalutamide, high-dose, hormone, second-line, therapy | Leave a comment »
According to a group of researchers at Queen’s University in Kingston, Ontario, a very low dose of nitroglycerin may be able to delay the progression of prostate cancer in men with a rising PSA after standard first-line treatment with radiotherapy or surgery. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: nitroglycerin, progressive, second-line | 2 Comments »
Today’s news reports address items on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: age, chemotherapy, external beam radiotherapy, outcomes, radical prostatectomy, second-line, transplant | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 